CM-cellulose (Whatman CM-52; H. Reeve Angel & Co., Inc.) was equilibrated with 0.01 M sodium acetate (pH 5.0) and packed in a 45 X 2.5-cm column. The pooled blastogenic activity from the DEAE column fractions, previously dialyzed against the starting buffer, was applied and the column eluted with a gradient of NaCI from 0.1 to 0.35 M.
Nuclease Assay. Nuclease activity was assayed by the acid-soluble technique as previously described (11) .
Polyacrylamide Gel Electrophoresis. Polyacrylamide gel electrophoresis was carried out essentially as described by Davis (12) with protein bands visualized with Coomassie Blue G250 (13) sodium dodecyl sulfate (SDS) 1 polyacrylamide gel electrophoresis was done by the method of Weber and Osborne (14) .
Lymphocyte Blastogenic Transformation Assay. Blastogenic activity was measured by [3H]thymidine incorporation by a gradient-separated monocyte population from human blood.
Heparinized whole blood, diluted with an equal volume of Eagles' minimal essential medium containing 100 U of penicillin and streptomycin and 2 mmol of L-glutamine/ml (MEM) (Grand Island Biological Co., Grand Island, N. Y.) was layered on Ficoll-Hypaque (Pharmacia Fine Chemicals Inc., Piscataway, N. J.). After centrifugation, the lymphocyte fraction was withdrawn and washed three times with MEM. The washed lymphocytes were then resuspended at a concentration of 1 × 106/ml in MEM containing 10% pooled human serum. To assay column fractions or eluates of polyacrylamide gel slices, 10-50 #! of the fraction was diluted with 1 ml of MEM-10% pooled human serum. Triplicate 100-pl samples of each dilution were transferred to wells of standard tissue culture microtiter plates (Falcon Labware, Div. of Becton, Dickinson & Co., Oxnard, Calif.) containing 100 #i of the lymphocyte preparation (100,000 cells). The plates were incubated for 5 d at 37°C in a humidified atmosphere containing 5% CO2. After this period, 0.5 #Ci of [methyl-aH] thymidine (6.7 Ci/mmol; New England Nuclear, Boston, Mass.) was added and after a further incubation of 18 h, the cells were harvested and washed on glass fiber disks using a semi-automatic cell harvester. The disks were dried and radioactivity measured in a toluene-based cocktail by liquid scintillation counting.
Enzyme Immunoassay of Streptococcal Blastogen A Antibodies. Levels of antibodies against streptococcal blastogen A were measured using an enzyme immunoassay which was similar to that described by Engvall and Perlmann. (15) Polystyrene tubes (12 × 75 ram) (Falcon Labware) were coated with homogeneous blastogen A by incubating at 37°C for 60 min with 1 ml of the protein (10 ng/ml) dissolved in 0.1 M Na2CO3 (pH 9.6). The tubes were stored overnight at 4°C then washed three times with 0.9% NaCI, 0.05% Tween-20. Serum to be assayed was diluted in phosphate-buffered saline (PBS) 0.05% Tween-20, 0.02% NAN3, and 1 ml of a series of dilutions (1/100, 1/300, 1/900, 1/2,700) were incubated in the coated tubes at 37°C for 30 rain. The tubes were washed as before and then incubated with 1 ml of goat anti-human gamma chain globulin-horse radish peroxidase conjugate. Conjugate was prepared (16) from the IgG fraction of goat anti-human gamma chain sera (N. L. Cappel Laboratories Inc., Cochranville, Pa.) and horse radish peroxidase, type VI (Sigma Chemical Co., St. Louis, Mo.). After washing as before, 1 ml of peroxidase substrate (0.04% orthophenylenediamine, 0.006% H202 in citrate-phosphate buffer, pH 5.0) (16) was incubated in the tubes at room temperature for 30 min when 0.5 ml of 2 M H2SO4 was added to stop the reaction. The absorbance at 493 nm of the colored product was measured by spectrophotometry. Control tubes not coated with antigen were treated identically with each serum dilution and the A493 values were subtracted. In sera with low antibody levels these control values represented a large fraction of the ahsorbance observed with antigen-coated tubes and therefore were critical for the determination ~Abbreviations used in thzs paper: MEM, Eagles' minimal essential medium; PBS, phosphate-buffered saline; SDS, sodium dodecyl sulfate; SPE, streptococcal pyrogenic exotoxin. of meaningful titers. The corrected A4aa values were plotted against the serum dilutions on a log/log scale. The antibody titer was arbitrarily set at that extrapolated serum dilution which would produce an A493 of 0.100. Anti-DNase B levels were determined by the microtiter technique of Nelson et al. (17) .
Enzyme Treatment of Streptococcal Blastogen
A. A sample of a homogeneous preparation of blastogen A (1/xg/mi) was incubated separately with 100 #g pancreatic RNase, 100 #g pronase, and I00 btg trypsin (all from Sigma Chemical Co.) for 60 min at 37°C. The samples, including a control incubated without enzyme, were heated at 100°C for 10 min to inactivate enzymes and then the residual activity was assayed for blastogenic activity.
Results

Purification of Streptococcal Blastogen A. The extracellular products of strain C203S
contained a single major peak of blastogenic activity when fractionated on DEAEcellulose ( Fig. 1) . The blastogenic activity overlapped streptococcal nuclease A and was completely separated from the earlier eluting nucleases B and D, which were assayed as reference markers. The blastogen peak was pooled and chromatographed on CM-cellulose at pH 5 ( Fig. 2 ). This procedure separated the blastogen from the bulk of other protein as well as from nuclease A. In most preparations, the blastogenic activity, hereafter referred to as streptococcal blastogen A, was homogeneous after CM chromatography (Fig. 3 ). An occasional contamination with nuclease A could be removed by rechromatography on CM-cellulose. The single band of protein on SDS polyacrylamide gel electrophoresis had a mobility characteristic of a mol wt of 17,500 (Fig. 3 ). 
Effect of Enzymes on Streptococcal Blastogen A.
The nature of blastogen A was examined by digestion with various enzymes. The activity is unaffected by pancreatic RNase but is destroyed by pronase and trypsin. The active portion of the blastogen is therefore likely to be a protein.
Heat Stability of Streptococcal Blastogen A. The heat stability of blastogen A was examined by measuring the activity remaining after various times of heating at 100°C. Blastogen A was rapidly and apparently irreversibly denatured by this treatment with <10% of the activity remaining after 5 min of heating. The purified material and the blastogenic activity in crude extracts from strain C203S were both affected. The blastogenic activity in crude extracellular products from all of the streptococcal strains listed in Table I showed kinetics of heat denaturation similar to the purified material from strain C203S.
Production of Blastogenic Activity by Various Streptococcal Strains.
The production of extracellular blastogenic activity by several strains of group A streptococci was examined in crude extracts prepared from stationary phase cultures (Table I) . The levels of blastogenic activity varied from 0.1 to nearly 30 stimulation U//~g of protein but all of the strains examined produced measurable lymphocyte transforming activity. It is possible that the blastogenic activity in some of the cultures was due to another streptococcal product but evidence from the enzyme immunoassay of antiblastogen A-IgG suggests that the production of blastogen A is a common property of group A streptococci. in the appearance of multiple bands of protein with a broad spectrum of electrophoretic mobility (Fig. 4a) . A companion gel was sliced and eluted and blastogenic activity was measured in the eluates. The peak of activity was not correspondent to the major protein bands that had barely detectable blastogenic activity. Instead, the biological activity was associated with minor protein bands of much higher mobility. In another experiment (data not shown) in which a similar gel was fractionated into thinner slices, two separate peaks of blastogenic activity was apparent, corresponding to the two protein bands. One explanation of these observations could be the * Stimulation unit was calculated as follows: (cpm of dilution of blastogen/ cpm of maximum stimulation) × dilution factor = stimulation units (in undiluted blastogen preparation). The value reported is from a dilution on the linearly decreasing portion of the titration curve (see Fig. 6 ).
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formation of oligomeric forms of blastogen A through disulfide cross linkage. In fact, the treatment of the blastogen A preparation with dithiothreitol before electrophoresis (Fig. 4 b) resulted in a marked reduction in the major protein bands and the generation of a previously absent protein species coincident with the blastogenic activity. This latter protein is of greater mobility than either of the two active species in the nonreduced blastogen A gel. If dithiothreitol treatment is prolonged, all of the slower migrating proteins are absent with the single band of protein remaining coincident with the blastogenic activity.
Relationship of Streptococcal Pyrogenic
Exotoxins to Blastogen A. The streptococcal pyrogenic exotoxins are mitogens produced by many strains of group A streptococci. To compare blastogen A with these entities, the electrophoretic mobilities of streptococcal pyrogenic exotoxins A, B, and C and that of blastogen A in polyacrylamide gels were determined (Table II) . Exotoxins A and C are obviously different in mobility from blastogen A, which has a mobility in the range of that of exotoxin B; this latter protein was present as two-charge isomers.
To further examine the possibility that blastogen A was identical with one of the streptococcal pyrogenic exotoxins, specific rabbit antisera were used in the lymphocyte stimulation assay. The blastogenic response to various concentrations of blastogen A was measured in the presence of antisera to the pyrogenic exotoxins. The results of such an experiment (Fig. 5) indicate that none of the antisera, with the possible exception of anti-exotoxin A, significantly affected the stimulation of lymphocytes by blastogen A, suggesting that the pyrogenic exotoxins are dissimilar antigenically from blastogen A.
A possibility existed that these antisera, even if directed toward blastogen A, could not inhibit the lymphocyte response. In a separate experiment, human serum shown to contain anti-blastogen A-IgG by enzyme immunoassay was incubated with lymphocytes and varying concentrations of blastogen A (Fig. 6) . As the results indicate, the lymphocyte transformation response to blastogen A was markedly inhibited in the presence of the anti-blastogen A serum. It would appear that inability of the antipyrogenic exotoxin sera to inhibit the lymphocyte response to blastogen A (Fig. 5 ) reflects antigenic differences between blastogen A and the exotoxins. 
Antibodies to Streptococcal Blastogen A m Human Sera. The humoral immunogenicity
of blastogen A was examined by means of an enzyme immunoassay for antibodies directed against this antigen m h.uman sera. The results of a survey of sera with a range of antibody titers against streptococcal DNase B are shown in Table III . Antibodies to blastogen A appear to be present in sera in which anti-DNase B levels are elevated. The relative levels of anti-blastogen A, with some exceptions, correspond to those of anti-DNase B. In certain sera, the anti-blastogen A level was undetectable although low levels of anti-DNase B were present. In this small group of sera, the The purified materials were electrophoresed on 7.5% polyacrylamide gels as in Materials and Methods. The mobilities of the proteins are relative to that of bromophenol blue.
infecting strains of streptococci were not available; however, it seems likely that blastogen A is a common antigen produced by a variety of streptococci.
Discussion
The present study has demonstrated the isolation in homogeneous form of a group A streptococcal extracellular product capable of stimulating lymphocyte blastogenesis. The protein, termed streptococcal blastogen A, has a mol wt of 17,500 and is susceptible to heat denaturation and readily forms disulfide cross-linked species, most of which are relatively inactive on lymphocytes.
A variety of streptococcal cellular, cell-bound, and extracellular proteins have the ability to induce lymphocyte blastogenesis. Abe and Alouf (6) have partially purified an extracellular blastogenic substance which appeared to have a mol wt of 50,000 as estimated by gel filtration and an isoelectric point near 4.7. This substance corresponds in size to a glycopeptide mitogen extracted from resting streptococci by Plate and Amos (4, 5). Seravalli and Taranta (1) have described an extracellular mitogen from the same group A streptococcal strain (C203S) that was the principal source of material used in the present study. In this case, the mitogenic substance appeared to be heterogeneous, with a major species of mol wt 26,000 and an isoelectric point of 6.9. However, in the present study the DEAE chromatograms of crude extracellular products from two distinct group A strains (C203S and $43) show the same pattern of blastogenic activity, a single major peak with little evidence for other blastogens. If indeed the mitogens described by Seravalli and Taranta (1) are separate species, they are not detectable by the fractionation techniques used to purify blastogen A. A possible explanation for the heterogeneity reported by these authors could be related to the observations of multiple disulfide linked forms on polyacrylamide gel electrophoresis (Fig. 4) .
Another group of mitogenic proteins that are produced by group A streptococci are the streptococcal pyrogenic exotoxins (SPE), also known as the streptococcal erythrogenic toxins (7) (8) (9) . Three distinct species of SPE exist with mol wt of 8,000, 17,500, and 13,000, respectively, for SPE A, B, and C. The molecular weight and electrophoretic mobility of SPE A and C are clearly different from blastogen A. Exotoxin B, however, is similar in mobility to blastogen A and has an identical molecular weight. Furthermore, exotoxin B exists as two charge isomers and two active forms ofblastogen A are separable by gel electrophoresis. Nauciel et al. (18) have reported that erythrogenic toxin (SPE-A) can be isolated in two distinct forms which are convertible to a single species by reduction. Similar behavior was observed with blastogen A in the present investigation, although multiple inactive and two active forms of blastogen A were converted to a single active species. This property appears to be shared by streptococcal nuclease B, which exists in multiple forms (19) , some of which are absent after reduction with dithiothreitol (Gray, E. D. Unpublished results). It may, therefore, be a more general property of streptococcal extracellular products. The lack of significant inhibition of lymphocyte stimulation by blastogen A in the presence of antisera to the streptococcal pyrogenic exotoxins appears to indicate that blastogen A is antigenically dissimilar to these entities. An alternative interpretation of these results is that the antigenic sites which specify the humoral antibodies are different from those involved in the lymphocyte blastogenic response. This appears to be the case with some systems (20) and under these circumstances, even if blastogen A was identical to one of the pyrogenic exotoxins, the antibodies against the toxins might not be directed at the antigenic site which interacts with lymphocytes. However, a recent study indicates that the mitogenic activity of erythrogenic toxin can be inhibited by specific rabbit antisera to the toxin (91). Furthermore, the blastogenic activity of blastogen A was inhibited by serum containing antibodies against this protein (Fig. 6 ). It appears that blastogen A is not closely antigenically related to the pyrogenic exotoxins. Further studies will be required to exclude the possibility that blastogen A may be identical with or related to one of the other known extracellular products of group A streptococci.
The lymphocyte stimulating substances isolated from streptococcal extracellular products have been termed mitogens, because they induce blastogenesis in lymphocytes from animals presumably unsensitized by streptococcal antigens (1, 2) . In the absence thus far of definitive evidence, the stimulating substance purified in the present investigation has been termed a blastogen blastogen A in human sera and their inhibition of lymphocyte stimulation suggest that the human response to blastogen A is by lymphocytes sensitized to the antigen. The possibility exists that blastogen A is also a nonspecific mitogen, stimulating unsensitized lymphocytes, and this will be a subject for future studies on lymphocytes from human cord blood. Streptococcal blastogen A is evidently produced by a wide variety of streptococci as evidence by the presence of antibodies to this protein in a small, randomly selected group of human sera. Furthermore, blastogenic activity has been directly detected in several group A strains (Table I) . Although this activity could be due to a variety of streptococcal products, it has similar chromatographic properties in two unrelated strains. If, indeed, blastogen A is a common streptococcal extracellular product, most adults will have been exposed to this antigen. The blastogenic response to blastogen A will, therefore, represent an index of the reactivity of an individual's immune system to a streptococcal antigen. A survey of such responses may allow the demonstration of altered reactivity in individuals with clinical evidence of post-streptococcal disease (acute nephritis, acute rheumatic fever, and rheumatic heart disease) and perhaps allow the identific~ion of those at risk for these diseases. Such a study employing the purified blastogen A is presently underway. Summary An extracellular product of group A streptococci which induces lymphocyte blastogenesis has been purified to homogeneity by DEAE-ce'llulose and CM-cellulose chromatography. The protein, termed streptococcal blastogen A, has a mol wt of 17,500 and is inactivated by protease treatment and by heating at 100°C. The purified blastogen gave rise to multiple protein bands on nondenaturing polyacrylamide gel electrophoresis, only two of which possessed blastogenic activity. Treatment of the protein with dithiothreitol before electrophoresis resulted in the apparent A group of human sera selected for differing levels ofanti-DNase B was assayed for anti-blastogen A levels by an enzyme immunoassay as described in Materials and Methods.
conversion of the multiple forms to a single active species. Blastogen A differs in electrophoretic mobility from the streptococcal pyrogenic exotoxins and its lymphocyte stimulating activity is not inhibited by rabbit antisera to the exotoxins. An enzyme immunoassay has been developed to measure human antibodies against blastogen A. A selection of sera with varying levels of anti-DNase B contained antiblastogen A-IgG.
